As the main component of DTH extract, corymbiferin may take responsibility for hypoglycemia and enhancement of insulin sensitivity due to its bases on 1,3,5- or 1,3,8-oxygenated systems, similar to bellidifolin and swerchirin that have been demonstrated to have blood-glucose-lowering effect in diabetic animals through enhancing insulin signaling transduction [16–19]. This evidence concerns the gene INS and Hypoglycemia.